Know Cancer

or
forgot password

Epidemiologic, Clinical and Genetic Profile of Prostate Cancer in Arab Countries


N/A
40 Years
80 Years
Open (Enrolling)
Both
Prostate Cancer

Thank you

Trial Information

Epidemiologic, Clinical and Genetic Profile of Prostate Cancer in Arab Countries


Inclusion/Exclusion Criteria for Normal Cohort

Inclusion Criteria:



- All study subjects should be able to provide informed consent

- Males or females ages 40 years or older (see section A8 for the rationale for the
inclusion of females)

- Individuals of Arab descent from Qatari peninsula without any personal or family
history of prostate cancer

Exclusion Criteria:

- Individuals with family history of prostate cancer

- Individuals not deemed in good overall health by the investigator will not be
accepted into the study

Inclusion/Exclusion Criteria for Prostate Cohort

Inclusion Criteria:



- All study subjects should be able to provide informed consent

- Males ages 40 years or older

- Individuals from the Qatari Peninsula whose ancestors up to three generations back
were natives of Qatar.

- Individuals undergoing Trans Rectal Ultrasound (TRUS) biopsy as dictated by their
standard clinical care

- Ultrasound OR digital rectal examination consistent with prostate disease OR A level
of PSA (Prostatic Specific Antigen) greater than 3.0

Exclusion Criteria:

• Patient refuses consent

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Cross-Sectional

Outcome Measure:

Identification of single nucleotide polymorphisms (SNPs) in genes associated with prostate cancer in the Qatari population.

Outcome Time Frame:

3 years

Safety Issue:

No

Authority:

United States: Institutional Review Board

Study ID:

0806009874

NCT ID:

NCT00801996

Start Date:

November 2008

Completion Date:

November 2013

Related Keywords:

  • Prostate Cancer
  • prostate cancer
  • genetics
  • Prostatic Neoplasms

Name

Location